Abstract
Mesenchymal stem cells (MSC) are adult-derived multipotent stem cells that have been derived from almost every tissue. They are classically defined as spindle-shaped, plastic-adherent cells capable of adipogenic, chondrogenic, and osteogenic differentiation. This capacity for trilineage differentiation has been the foundation for research into the use of MSC to regenerate damaged tissues. Recent studies have shown that MSC interact with cells of the immune system and modulate their function. Although many of the details underlying the mechanisms by which MSC modulate the immune system have been defined for human and rodent (mouse and rat) MSC, much less is known about MSC from other veterinary species. This knowledge gap is particularly important because the clinical use of MSC in veterinary medicine is increasing and far exceeds the use of MSC in human medicine. It is crucial to determine how MSC modulate the immune system for each animal species as well as for MSC derived from any given tissue source. A comparative approach provides a unique translational opportunity to bring novel cell-based therapies to the veterinary market as well as enhance the utility of animal models for human disorders. The current review covers what is currently known about MSC and their immunomodulatory functions in veterinary species, excluding laboratory rodents.
Original language | English (US) |
---|---|
Pages (from-to) | 207-217 |
Number of pages | 11 |
Journal | Comparative Medicine |
Volume | 63 |
Issue number | 3 |
State | Published - Jun 2013 |
Keywords
- Adipose tissue
- AT
- BM
- Bone marrow
- CB
- CT
- DC
- Dendritic cell
- IDO
- Indoleamine 2;3-dioxygenase; MSC
- Mesenchymal stem cells; PGE2
- Prostaglandin E2; VEGF
- Umbilical cord blood
- Umbilical cord tissue
- Vascular endothelial growth factor
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)
- veterinary(all)